| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |